Arxis, Inc. Form 424B3 — Oct 29, 2026
Arxis, Inc. (Nasdaq: ARXS) filed Prospectus Supplement No. 2 on October 29, 2026, registering the resale by selling stockholders of up to 13,351,964 shares of Class A common stock issued to former Omnetics shareholders in the August 17, 2026 merger. The company itself is not selling shares and will receive no proceeds.
Key figures
- Total Assets
- 143490272
- Cash Position
- 28736058
- Deal Value Usd
- 770000000
- Gross Proceeds
- 0
- Shares Offered
- 13351964
- Shares Outstanding
- 422895
- Cash escrow usd
- 8000000
- Merger close date
- 2026-08-17
- Goodwill pro forma usd
- 354600000
- Intangibles acquired usd
- 462000000
- Omnetics 2025 revenue usd
- 113518473
- Price per share merger usd
- 57.6
- Omnetics 2025 net income usd
- 27476481
- Omnetics h1 2026 revenue usd
- 66547727
- Consideration transferred usd
- 777074416
- Pro forma diluted eps 9m 2026
- 0.34
- Pro forma revenue 9m 2026 usd
- 1608345000
- Omnetics h1 2026 net income usd
- 18215524
- Pro forma net income 9m 2026 usd
- 145954000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.